Carbamazepine Tablet, Extended Release
Product Images NDC 72516-021

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 72516-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oryza Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

200 (Carbamazepine 200mg)

This text contains information about Carbamazepine Extended-Release Tablets, including dosage instructions, storage guidance, manufacturer details, and cautionary notes to protect from moisture. The tablets must be swallowed whole and not crushed or chewed. The medication should be dispensed with an enclosed Medication Guide. It is manufactured by Oryza Pharmaceuticals, Inc. and is made in China. The tablets are available in bottles containing 100 tablets, each with 200 mg of Carbamazepine USP.*

FDA Label Image

400 mg (Carbamazepine 400mg)

This text provides information about Carbamazepine Extended-Release Tablets, with each tablet containing 400 mg of Carbamazepine USP. It includes details such as dosage instructions, storage conditions, manufacturer information, and a reminder to keep the medication out of reach of children. The tablets should be swallowed whole and not crushed or chewed. The text also emphasizes the importance for pharmacists to dispense the medication with the enclosed Medication Guide.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.